Literature DB >> 18634872

The ubiquitin-proteasome system in cardiac dysfunction.

Giulia Mearini1, Saskia Schlossarek, Monte S Willis, Lucie Carrier.   

Abstract

Since proteins play crucial roles in all biological processes, the finely tuned equilibrium between their synthesis and degradation regulates cellular homeostasis. Controlling the quality of proteome informational content is essential for cell survival and function. After initial synthesis, membrane and secretory proteins are modified, folded, and assembled in the endoplasmic reticulum, whereas other proteins are synthesized and processed in the cytosol. Cells have different protein quality control systems, the molecular chaperones, which help protein folding and stabilization, and the ubiquitin-proteasome system (UPS) and lysosomes, which degrade proteins. It has generally been assumed that UPS and lysosomes are regulated independently and serve distinct functions. The UPS degrades both cytosolic, nuclear proteins, and myofibrillar proteins, whereas the lysosomes degrade most membrane and extracellular proteins by endocytosis as well as cytosolic proteins and organelles via autophagy. Over the last two decades, the UPS has been increasingly recognized as a major system in several biological processes including cell proliferation, adaptation to stress and cell death. More recently, activation or impairment of the UPS has been reported in cardiac disease and recent evidence indicate that autophagy is a key mechanism to maintain cardiac structure and function. This review mainly focuses on the UPS and its various components in healthy and diseased heart, but also summarizes recent data suggesting parallel activation of the UPS and autophagy in cardiac disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18634872     DOI: 10.1016/j.bbadis.2008.06.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  61 in total

1.  Adrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in mice.

Authors:  Saskia Schlossarek; Friederike Schuermann; Birgit Geertz; Giulia Mearini; Thomas Eschenhagen; Lucie Carrier
Journal:  J Muscle Res Cell Motil       Date:  2011-11-11       Impact factor: 2.698

2.  Regulation of Abro1/KIAA0157 during myocardial infarction and cell death reveals a novel cardioprotective mechanism for Lys63-specific deubiquitination.

Authors:  Lucia Cilenti; Meenakshi P Balakrishnan; Xiao-Liang Wang; Camilla Ambivero; Martin Sterlicchi; Federica del Monte; Xin L Ma; Antonis S Zervos
Journal:  J Mol Cell Cardiol       Date:  2010-12-30       Impact factor: 5.000

3.  Enhancement of proteasome function by PA28α overexpression protects against oxidative stress.

Authors:  Jie Li; Saul R Powell; Xuejun Wang
Journal:  FASEB J       Date:  2010-11-23       Impact factor: 5.191

Review 4.  Proteotoxicity: an underappreciated pathology in cardiac disease.

Authors:  Marco Sandri; Jeffrey Robbins
Journal:  J Mol Cell Cardiol       Date:  2013-12-28       Impact factor: 5.000

Review 5.  The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy.

Authors:  Lucie Carrier; Saskia Schlossarek; Monte S Willis; Thomas Eschenhagen
Journal:  Cardiovasc Res       Date:  2009-07-17       Impact factor: 10.787

6.  Myosin light chain phosphorylation is critical for adaptation to cardiac stress.

Authors:  Sonisha A Warren; Laura E Briggs; Huadong Zeng; Joyce Chuang; Eileen I Chang; Ryota Terada; Moyi Li; Maurice S Swanson; Stewart H Lecker; Monte S Willis; Francis G Spinale; Julie Maupin-Furlowe; Julie R McMullen; Richard L Moss; Hideko Kasahara
Journal:  Circulation       Date:  2012-10-24       Impact factor: 29.690

Review 7.  Molecular mechanisms underlying cardiotoxicity of novel cancer therapeutics.

Authors:  Simon Braumann; Stephan Baldus; Roman Pfister
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

8.  Clarifying the cardiac proteasome paradox: protein quality control.

Authors:  Christopher C Glembotski
Journal:  Circ Res       Date:  2012-08-17       Impact factor: 17.367

9.  MAFbx/Atrogin-1 is required for atrophic remodeling of the unloaded heart.

Authors:  Kedryn K Baskin; Meredith R Rodriguez; Seema Kansara; Wenhao Chen; Sylvia Carranza; O Howard Frazier; David J Glass; Heinrich Taegtmeyer
Journal:  J Mol Cell Cardiol       Date:  2014-03-18       Impact factor: 5.000

10.  Modulation of muscle atrophy, fatigue and MLC phosphorylation by MuRF1 as indicated by hindlimb suspension studies on MuRF1-KO mice.

Authors:  Siegfried Labeit; Christine H Kohl; Christian C Witt; Dittmar Labeit; Jeong Jung; Henk Granzier
Journal:  J Biomed Biotechnol       Date:  2010-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.